A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 14 July 2013 |
| Author/s |
author: Eva Szabo Sean Khozin Anish Thomas Giuseppe Giaccone |
| Publication date | July 14, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |